PBS approval for T-Cell lymphoma patients

The cost of medicines to treat diabetes, cancer, arthritis, asthma and eye disease will be slashed from 1 April 2018 under a massive new round of Turnbull government subsidies.

The government will list a range of new medicines to treat cancer,
including pralatrexate – known as Folotyn – which will provide a new treatment option for T-Cell lymphoma, helping about 440 patients each year.

This is one of 11 drugs added to the Pharmaceutical Benefits Scheme (PBS) on April 1, saving Australian patients thousands of dollars, Health Minister Greg Hunt says.

Read more about the PBS listings here: https://www.smh.com.au/politics/federal/diabetes-cancer-and-arthritis-sufferers-to-benefit-from-new-subsidies-20180325-p4z648.html

 

Sign up to our Newsletter

Copyright © 2022. Lymphoma Australia
Share This

Newsletter Sign Up

Contact Lymphoma Australia Today!